Entity Type
Company
SEC filings, ownership reports, and insider transactions for CIK 0001982708.
Entity Type
Company
Total Filings
38
Latest Filing
09 Apr 2026
Industry
In Vitro & In Vivo Diagnostic Substances
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
20-F/A filed on 09 Apr 2026 for CIK 0001982708.
20-F/A filed on 09 Apr 2026 for CIK 0001982708.
Return Loop
A newly filed 20-F/A can change the filing history, ownership context, or next research path for Anbio Biotechnology.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
07 Apr 2026
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 07 Apr 2026.
Benchmark Context
Anbio Biotechnology has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Anbio Biotechnology has filed 38 SEC EDGAR filings since 27 Dec 2023. Common forms include 20-F/A, 3, 20-F, 6-K and more.
Recent SEC filings for Anbio Biotechnology with direct links to document and filing folders.
Anbio Biotechnology files with the SEC under CIK 0001982708. This page aggregates EDGAR filings and related ownership activity.
Industry: In Vitro & In Vivo Diagnostic Substances.